PANCREATIC ACINAR CELL CARCINOMA
Clinical trials for PANCREATIC ACINAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ACINAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ACINAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical stem cell combo aims to outsmart tough cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment for people with metastatic pancreatic or breast cancer. The goal is to see if a combination of high-dose chemotherapy drugs, vitamins, and the patient's own stem cells is safe and can overcome the cancer's resistance to treatment.…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE1 • Sponsor: General Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Targeted drug trial aims to keep pancreatic cancer from coming back
Disease control Recruiting nowThis study is testing if adding the drug olaparib after surgery and chemotherapy can help prevent pancreatic cancer from returning. It is for patients whose cancer has been surgically removed and who have specific genetic mutations (BRCA1, BRCA2, or PALB2). Participants will take…
Matched conditions: PANCREATIC ACINAR CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC